Ads
related to: therapy notes reviewstherapynotes.com has been visited by 100K+ users in the past month
Search results
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $10 (or More), Say Analysts
TipRanks via Yahoo Finance· 8 hours agoThe markets are on a solid upward trend this year, with the S&P 500’s year-to-date gain nearing 16%....
New Guidance on CGRPs: How/Will it Shape Clinical Practice?
Medscape· 20 hours ago/Will it Change Clinical Practice? A position statement released by the American Headache Society...
What happened to the 25 bills Senate leaders touted as fixes for health care in RI?
The Providence Journal via Yahoo News· 16 hours agoPhysical therapy licensing (S2718): This act sought to streamline physical therapy licensing by...
Research reports improvements in survival rates in patients with metastatic prostate cancer
Medical Xpress· 8 hours agoMetastatic prostate cancer accounts for 5–10% of all prostate cancer diagnoses, but it is responsible for nearly 50% of prostate cancer-related deaths. Since 2015, the prognosis of metastatic ...
A terrifying seizure, recording studio attempts and hope: Celine Dion’s new doc is harrowing
NY Post via Yahoo News· 2 days agoRated PG (thematic material and...who suffers from a rare neurological disorder called stiff person...
Experts Love These Top Red Light Therapy Devices for Neck
Harper's Bazaar via Yahoo News· 6 days agoThe best red light therapy devices for the neck help stimulate collagen, smooth fine lines, and...
Rising Popularity of “Magic” Amanita Mushrooms Raises Alarms – Scientists Warn of Serious Dangers
SciTechDaily· 1 hour agoNew research shows a concerning increase in interest in the highly toxic Amanita muscaria mushroom,...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 5 hours agoThe submission also includes results from the Phase 3 GRAVITI investigational study of TREMFYA ® SC induction therapy in adult patients with moderately to severely active ...
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.1%
ETF DAILY NEWS· 5 days agoTaysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) traded down 4.1% on Friday . The company traded as low as $3.95 and last traded at $4.00. 191,240 shares were traded during trading ...
Zerlasiran shows promise in phase 2 study for cardiovascular risk By Investing.com
Investing.com· 11 hours agoSilence Therapeutics plc (NASDAQ:SLN), a biotech firm focusing on RNA interference (RNAi) therapies,...